Effect of Different Types of Intermittent Fasting on Biochemical and Anthropometric Parameters among Patients with Metabolic-Associated Fatty Liver Disease (MAFLD)-A Systematic Review.
MAFLD
diet
intermittent fasting
liver
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
26 Dec 2021
26 Dec 2021
Historique:
received:
25
11
2021
revised:
21
12
2021
accepted:
24
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
27
1
2022
Statut:
epublish
Résumé
Metabolic-associated fatty liver disease (MAFLD), previously called non-alcoholic fatty liver disease (NAFLD), is the most common chronic liver disease worldwide. It is characterised by excessive fat accumulation in hepatocytes. Currently, no pharmacological therapy is effective for this disease, so non-pharmacological alternatives such as diet, supplementation or physical activity are being sought. For this reason, we reviewed the available databases to analyse the studies conducted to date using different modifications of intermittent fasting among patients with MAFLD. Eight studies using this dietary strategy were included in this review. The results obtained in the different trials are varied and do not allow a clear determination of the effect of the different types of intermittent fasting on anthropometric and biochemical parameters among patients with MAFLD. However, this type of diet seems to show some therapeutic potential, but further studies are needed.
Identifiants
pubmed: 35010966
pii: nu14010091
doi: 10.3390/nu14010091
pmc: PMC8747070
pii:
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Références
J Clin Med. 2021 Apr 13;10(8):
pubmed: 33924482
Diabetes Care. 2018 Feb;41(2):372-382
pubmed: 29358469
J Acad Nutr Diet. 2015 Aug;115(8):1203-12
pubmed: 25857868
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Diseases. 2017 Oct 22;5(4):
pubmed: 29065499
Metabolism. 2016 Aug;65(8):1038-48
pubmed: 26823198
Nutrients. 2017 Sep 06;9(9):
pubmed: 28878197
Obesity (Silver Spring). 2020 Jul;28 Suppl 1:S29-S37
pubmed: 32700827
J Clin Transl Hepatol. 2020 Mar 28;8(1):76-86
pubmed: 32274348
Nutrients. 2019 Nov 26;11(12):
pubmed: 31779112
JHEP Rep. 2021 Feb 17;3(3):100256
pubmed: 33898960
BMC Gastroenterol. 2019 Dec 18;19(1):219
pubmed: 31852444
Cells. 2020 Jan 10;9(1):
pubmed: 31936799
Diabetes Res Clin Pract. 2021 Aug;178:108951
pubmed: 34273453
Cochrane Database Syst Rev. 2021 Jan 29;1:CD013496
pubmed: 33512717
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S209-S216
pubmed: 28017631
J Hepatol. 2019 Mar;70(3):531-544
pubmed: 30414863
Isr Med Assoc J. 2021 Feb;23(2):94-98
pubmed: 33595214
J Pediatr. 2013 Mar;162(3):496-500.e1
pubmed: 23084707
Gastroenterology. 2011 Jan;140(1):124-31
pubmed: 20858492
Metabolism. 2020 Oct;111:154336
pubmed: 32777443
Nutrients. 2019 Nov 12;11(11):
pubmed: 31726714
Annu Rev Nutr. 2017 Aug 21;37:371-393
pubmed: 28715993
J Clin Med. 2019 Oct 09;8(10):
pubmed: 31601019
Nutrients. 2020 Apr 29;12(5):
pubmed: 32365676
Metab Syndr Relat Disord. 2020 Dec;18(10):450-461
pubmed: 32780629
J Hepatol. 2016 Jun;64(6):1388-402
pubmed: 27062661
Public Health Nutr. 2014 Feb;17(2):396-406
pubmed: 23182306
Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):906-915
pubmed: 31377182
J Hepatol. 2017 Oct;67(4):829-846
pubmed: 28545937
Sci Rep. 2019 Aug 2;9(1):11232
pubmed: 31375753
High Blood Press Cardiovasc Prev. 2020 Aug;27(4):271-280
pubmed: 32564204
Dig Liver Dis. 2010 May;42(5):320-30
pubmed: 20207596
Complement Ther Med. 2019 Dec;47:102187
pubmed: 31779987
Nutr Res. 2012 Dec;32(12):947-55
pubmed: 23244540
World J Hepatol. 2015 Mar 27;7(3):575-82
pubmed: 25848481
Int J Vitam Nutr Res. 2021 Jun;91(3-4):242-250
pubmed: 32003649
Diabetes Res Clin Pract. 2020 Jul;165:108226
pubmed: 32446800
N Engl J Med. 2010 Sep 30;363(14):1341-50
pubmed: 20879883
J Am Coll Nutr. 2017 Nov-Dec;36(8):640-645
pubmed: 28922096
Nutrients. 2021 Jul 30;13(8):
pubmed: 34444811